Iterum Therapeutics to Present at the 9th Annual SVB Leerink Global Healthcare Conference Feb 19, 2020
Iterum Therapeutics Announces $52 Million Private Placement with New and Existing Investors Jan 17, 2020
Iterum Therapeutics Announces Completion of Enrollment in Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infection Dec 26, 2019
Iterum Therapeutics Announces Topline Results from Phase 3 Clinical Trial of Oral and IV Sulopenem for the Treatment of Complicated Intra-abdominal Infections Dec 10, 2019
Iterum Therapeutics Announces Completion of Enrollment in Phase 3 Clinical Trial of Oral and IV Sulopenem in Complicated Urinary Tract Infection Nov 18, 2019
Iterum Therapeutics to Present Data on Uncomplicated Urinary Tract Infections at ASM Microbe 2019 Jun 21, 2019